Literature DB >> 1450586

The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome.

K L Brugge1, S Nichols, D Delis, T Saitoh, D Truaner.   

Abstract

Down's syndrome (DS) is a genetic disorder involving an excess of chromosome 21 (trisomy 21) in approximately 96% of the cases and comprises approximately 15% of the population with mental retardation (Heller, 1969). In addition to the constitutional mental deficiencies associated with the syndrome many DS patients develop dementia associated with Alzheimer's disease (AD) in their later years of life (Thase et al., 1984). The genetic locus for Cu,Zn-superoxide dismutase (SOD1), a key enzyme in free radical metabolism, is located on chromosome 21, and the activity level of this enzyme is elevated by approximately 50% in a variety of cells of DS patients (see Kedziora and Bartosz, 1988; Sinet, 1982). Because alterations in free radical metabolism may be involved in neuronal death and may be associated with a number of pathological manifestations of DS, it is important to understand the role of free radical metabolism in cognitive impairments of DS, the topic discussed in this chapter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450586     DOI: 10.1007/978-3-0348-7460-1_19

Source DB:  PubMed          Journal:  EXS        ISSN: 1023-294X


  3 in total

Review 1.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

2.  Down's syndrome and myocardial reperfusion injury.

Authors:  Susheel Kumar; Richard Jonas
Journal:  J Saudi Heart Assoc       Date:  2010-09-09

3.  Epigenetic dysregulation in the developing Down syndrome cortex.

Authors:  Nady El Hajj; Marcus Dittrich; Julia Böck; Theo F J Kraus; Indrajit Nanda; Tobias Müller; Larissa Seidmann; Tim Tralau; Danuta Galetzka; Eberhard Schneider; Thomas Haaf
Journal:  Epigenetics       Date:  2016-05-31       Impact factor: 4.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.